"Iziqondiso Zokujova I-insulin Ngaphandle Kwezinaliti Ezigulini Ezinesifo Sikashukela" yakhululwa e-China, ephawula ukungena ngokusemthethweni komjovo we-insulin engenanaliti ngokulandelana emtholampilo waseChina wesifo sikashukela, futhi yenze iChina yaba yizwe elisemthethweni lokugqugquzela ukuntula inaliti. umjovo womtholampilo wobuchwepheshe.
Ngesikhathi esifanayo, kwaqalwa ukugqugquzelwa ezweni lonke lomjovo we-insulin engenanaliti, futhi kwasetshenziswa imijovo engenanaliti emawadini ezibhedlela ezingamakhulu eChina, okwaba umjovo wokuqala ongenanaliti owamukelwa njengethuluzi lokwelapha.
Njengebhizinisi elihamba phambili emkhakheni womjovo ongenanaliti e-China, ukusungulwa okusha okuqhubekayo kobuchwepheshe bejethi ye- "TECHiJET" kubone umklamo ofanayo wemodeli ye-"TECHiJET" ye-injection fluid mechanics engenanaliti enezidakamizwa ezahlukene, kanye nokulawula okunembile. yokujula komjovo nendawo yokusabalalisa., ukubambisana nomuthi ukuze kuzuzwe ukuqala okuhle kakhulu kwesenzo.Ngakho-ke, isirinji engenanaliti ye-TECHiJET ayilona nje ithuluzi elilula lesingeniso, kodwa futhi iwuhlelo lokwelapha lokulethwa kwezidakamizwa.
Ngaphambi kokufakwa isicelo emtholampilo, i-"TECHiJET" yenze inqwaba yezilingo ze-clinical res earch.
"I-Pharmacokinet ics ne-Pharmacodyna mics Study of Humalog without Needle Injection" eyenziwa nguProfess noma uLi Qifu we-First Affiliated H ospital yaseChongqing Medical University ngo-2015 iqinisekisa ukuthi uma iqhathaniswa neirinji engenanaliti ye "TECHiJET" engenanaliti. isipetu, ukumuncwa kwe-insulin Ngokushesha futhi eduze nephethini ye-physiological secretion insulin;
Ngo-2016, ucwaningo oluthi "Ukuqhathanisa umphumela womjovo wenaliti -fr ee kanye nepeni le-insu lin yendabuko ekulawuleni ushukela we-bloo d kanye namazinga e-insulin ezigulini ezine-T 2DM" ngokuhlanganyela okwenziwe nguProfesa Xiao Xinhua wasePeking Union Medical College H. osp ital kanye noSolwazi uGuo Lix osesibhedlela saseBeijing baqinisekisa ukuthi: "Qu ick Shure" umjovo ongenanaliti Uma kuqhathaniswa nezinaliti h,
I-postprandia l ukulawula ushukela wegazi kungcono, futhi ukushintshashintsha kokushukela wegazi ngemuva kokudla kuncane;
Kusukela ngo-2018, yathatha iminyaka emi-2 futhi yayiholwa nguProfess noma u-Ji Linong wase-Beijing Peop le's Hospital futhi ngokuhlanganyela yethula ucwaningo lwe-P hase III olunama-tals angu-10 aphezulu ezibhedlela.Ucwaningo "LAMAHHALA" olusebenzisa i-"T ECHiJET" i-yringe engenanaliti okwamanje inkulu kakhulu emhlabeni.Abaphenyi babheka inkomba yegolide yokulawula ushukela wegazi "i-glycat ed hemoglobin" njengenkomba eyinhloko yokusebenza ngempumelelo kwe-obs er vation, ngaphansi kwethimba lochwepheshe abaphezulu be-endocrinology baseC Hina, iqinisekise izinzuzo ze-"TECHiJET" engenanaliti. ubuchwepheshe bubheka futhi buthuthukise ikhono lokusungula izinto ezintsha, kodwa buphinde bubonise ukubaluleka kwe-ed China Innovation kanye nenani lesicelo somtholampilo somtholampilo we-arch on inaliti yokujova ubuchwepheshe.Ucwaningo "LAMAHHALA" luqinisekise iziphetho ezilandelayo:
Uma kuqhathaniswa ne-insulin nenaliti h, uguquko olusuka kusisekelo se-HbA1c ngaphandle kwenaliti lwalungelona oluphansi noma eqenjini le-insulin, futhi lwalunobukhulu bezibalo kanye nokubalulekile komtholampilo; imithamo ye-insulin kunemijovo yepeni ye-insulin;Ayikho i-ion yenaliti ye-insulin ejovayo, izehlakalo zokusabela okubi kwe-ion endaweni yomjovo ziphansi, futhi akukho ukucindezelwa okwenzekayo; Umjovo we-insulin ongafakwa inaliti ubangela ubuhlungu obuncane nangaphezulu. ukwaneliseka kwesiguli, okungase kuthuthukise ukuthotshelwa kwesiguli."I-TECHiJET" izoqhubeka nokuba ubuchwepheshe bomjovo wenaliti ohamba phambili emhlabeni wonke njengomgogodla wokuzuza iziguli nokwenza ukunakekelwa kwezokwelapha kuphephe.Kuyisibopho kanye nomgomo we-"T ECHiJET" ukukhuthaza inqubekelaphambili yesayensi nezobuchwepheshe emnothweni wezokwelapha kazwelonke, kanye nombono "wokuxilonga okungenanaliti nokwelapha, okwenza umhlaba ube indawo engcono" ngokuqinisekile kungafinyelelwa ngokushesha ngangokunokwenzeka.
Isikhathi sokuthumela: Oct-13-2022